Evidence map›Paper›PMID 36878553›Full record

ArticleThe Journal of veterinary medical science2023

Antimicrobial resistance profiles of Campylobacter jejuni and Salmonella spp. isolated from enteritis patients in Japan.

Yoshimasa Sasaki, Tetsuya Ikeda, Kenzo Yonemitsu, Makoto Kuroda, Miho Ogawa, Ryuji Sakata, Masashi Uema, Yoshika Momose, Kenji Ohya, Maiko Watanabe and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of veterinary medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Microorganisms · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Yoshimasa SasakiDivision of Biomedical Food Research, National Institute of Health Sciences, Kanagawa, Japan.
Tetsuya IkedaDepartment of Infectious Diseases, Hokkaido Institute of Public Health, Hokkaido, Japan.
Kenzo YonemitsuMurayama Branch, National Institute of Infectious Diseases, Tokyo, Japan.
Makoto KurodaPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.
Miho OgawaDepartment of Bacteriology, BML Inc., Saitama, Japan.
Ryuji SakataDepartment of Bacteriology, BML Inc., Saitama, Japan.
Masashi UemaDivision of Biomedical Food Research, National Institute of Health Sciences, Kanagawa, Japan.
Yoshika MomoseDivision of Biomedical Food Research, National Institute of Health Sciences, Kanagawa, Japan.
Kenji OhyaDivision of Microbiology, National Institute of Health Sciences, Kanagawa, Japan.
Maiko WatanabeDivision of Microbiology, National Institute of Health Sciences, Kanagawa, Japan.
Yukiko Hara-KudoDivision of Microbiology, National Institute of Health Sciences, Kanagawa, Japan.
Masashi OkamuraDivision of Veterinary Science, Department of Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan.
Tetsuo AsaiDepartment of Applied Veterinary Science, The United Graduate School of Veterinary Science, Gifu University, Gifu, Japan.
National Institute of Health Sciences · JPObihiro University of Agriculture and Veterinary Medicine · JPSaitama Prefecture · JPGifu University · JPHokkaido Institute of Public Health · JPMurayama Medical Center · JPNational Institute of Infectious Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the antimicrobial resistance of Campylobacter jejuni and Salmonella spp. isolated from patients with enteritis will aid in therapeutic decision-making. This study aimed to characterize C. jejuni and Salmonella spp. isolates from patients with enteritis. For C. jejuni, the resistance rates against ampicillin, tetracycline, and ciprofloxacin were 17.2%, 23.8%, and 46.4%, respectively. All the C. jejuni isolates were susceptible to erythromycin, which is recommended as a first-choice antimicrobial if Campylobacter enteritis is strongly suspected. C. jejuni was classified into 64 sequence types (STs), and the five major STs were ST22, ST354, ST21, ST918, and ST50. The ciprofloxacin-resistance rate of ST22 was 85.7%. For Salmonella, the resistance rates against ampicillin, cefotaxime, streptomycin, kanamycin, tetracycline, and nalidixic acid were 14.7%, 2.0%, 57.8%, 10.8%, 16.7%, and 11.8%, respectively. All the Salmonella spp. isolates were susceptible to ciprofloxacin. Therefore, fluoroquinolones are the recommended antimicrobials against Salmonella enteritis. S. Thompson, S. Enteritidis, and S. Schwarzengrund were the three most prevalent serotypes. The two cefotaxime-resistant isolates were serotyped as S. Typhimurium and were found to harbor bla

Indexed as

Anti-Infective AgentsCampylobacter InfectionsCampylobacter jejuniEnteritisAmpicillinAnimalsAnti-Bacterial AgentsCefotaximeCiprofloxacinDrug Resistance, BacterialJapanMicrobial Sensitivity TestsSalmonellaTetracyclineAmpicillinAnti-Bacterial AgentsAnti-Infective AgentsCefotaximeCiprofloxacinTetracyclineantimicrobial resistanceCampylobacterenteritisSalmonella

Identifiers

PMID36878553
PMCPMC10139799
OpenAlexW4323021094

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.